Temperature excursions cost pharma an estimated $35 billion a year as biologics, GLP-1s and cell and gene therapies raise cold chain stakes.
|Articles|May 15, 2018
Sonoco ThermoSafe and Elpro sponsor the Leading Minds seminar
Advertisement
The two companies, both leaders in pharma cold-chain technologies, are sponsoring a seminar on June 6-7 for qualified industry participants. Topics include:
- Cost efficiencies in CRT shipping
- Updates to USP <1079> and <659> and their effects on temperature excursion management
- Qualifying processes for reusing packaging
- Success in direct-to-patient clinical trial logistics
The seminar is being held at Normandy Farm, a historic site just outside Philadelphia. Click
Advertisement
Related to this article
Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
In this week's Pharma Pulse, DHL breaks ground on a new cold chain hub at Singapore's Changi Airport, a new report finds pharma's commercial model in the middle of a fundamental reset, and the FDA grants accelerated approval to sevabertinib.
Valerie Bandy of Tecsys on where 340B rebate mechanics threaten pharmacy purchasing, and how stakeholders can prevent disruption.
CMS says 40 states and Puerto Rico have signed on to the GENEROUS Model, which applies MFN pricing to Medicaid drugs through state-invoiced rebates.
Informa's invitation-only Leadership Summit returns to CPHI Milan Oct. 6 as executives weigh sourcing, medicine security and reshoring pressure.
The EU's pharma reform makes market protection more conditional. Here is how US drugmakers, especially startups, can adapt and use IP to complement it.
The White House said Medicaid programs in all 50 states, D.C. and Puerto Rico now receive MFN prices, with nearly $65 billion in savings over a decade.
Advertisement
Advertisement